AMGN vs GILD: Intrinsic Value and Buy-Below Price
Amgen Inc. and Gilead Sciences Inc. side by side, from the snapshot published 20 Nov 2026, 22:04 UTC. Both are in the Healthcare sector. Prices as of 20 Nov 2026 close
Side by side
| AMGN | GILD | |
|---|---|---|
| Beer Score | 87/100 | 100/100 |
| Zone | Pure Beer | Pure Beer |
| Valuation method | Owner earnings | Owner earnings |
| Growth-priced | No flag published | No flag published |
| Price | $435.64 | $166.43 |
| Model value | $378.13 | $206.64 |
| Pure Beer below | $472.66 | $258.30 |
| Good Pour below | $630.21 | $344.40 |
| Price vs Pure Beer level | 7.8% below | 35.6% below |
| Priced-in yearly growth (5 yr) | 11.5% | 2.9% |
| Quote date | 20 Nov 2026 | 20 Nov 2026 |
Filed financial figures appear on each stock page only where an SEC accession number and period end are published. Dated model estimates are not price targets or recommendations.
AMGN vs GILD questions
Is AMGN or GILD cheaper by model value?
GILD has the higher published model value relative to its price (Beer Score 100/100, Pure Beer) than AMGN (Beer Score 87/100, Pure Beer). This compares dated model estimates, not future returns.
What are the buy-below prices for AMGN and GILD?
AMGN: Pure Beer below $472.66 · now $435.64 (in zone, 7.8% below). GILD: Pure Beer below $258.30 · now $166.43 (in zone, 35.6% below).
What growth is priced into AMGN and GILD?
AMGN: The market is pricing in 11.5% yearly growth for 5 years. GILD: The market is pricing in 2.9% yearly growth for 5 years.
Keep exploring
AMGN valuation · GILD valuation · Healthcare sector · Undervalued Healthcare Stocks · AMGN vs TMO · AMGN vs PFE · AMGN vs DHR · GILD vs TMO · GILD vs PFE · DHR vs GILD